Solexa Closes $17M in Second Financing Round | GenomeWeb

NEW YORK, Sept. 24 – Solexa, a UK-based developer of high-throughput technology, has closed on roughly $12 million in its second round of venture capital financing, the company said on Monday.

Nick McCooke, Solexa's president and managing director, told GenomeWeb that the cash will be used to help create “the next generation of DNA sequencing tools.” McCooke reckons this recent cash infusion should be enough help the company meet that goal, which he said would likely happen within two years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.